Home/Pipeline/GSK Collaboration Program

GSK Collaboration Program

Cancers and Autoimmune Diseases

Discovery/Pre-clinicalActive

Key Facts

Indication
Cancers and Autoimmune Diseases
Phase
Discovery/Pre-clinical
Status
Active
Company

About Viome Life Sciences

Viome Life Sciences is a private biotech firm pioneering a novel approach to chronic disease and cancer by analyzing the functional activity of the human microbiome. Its core technology platform leverages metatranscriptomics and AI to decode biological data from over 300,000 specimens, aiming to shift healthcare from treatment to prevention. The company has secured significant funding, including a $54 million raise, and is expanding a collaboration with GSK to develop new therapeutic interventions for cancers and autoimmune diseases.

View full company profile